Charles Schwab’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$596K Buy
189,315
+19,341
+11% +$60.9K ﹤0.01% 3079
2025
Q1
$534K Buy
169,974
+68,310
+67% +$214K ﹤0.01% 3061
2024
Q4
$441K Sell
101,664
-19,629
-16% -$85.2K ﹤0.01% 3181
2024
Q3
$324K Buy
121,293
+12,503
+11% +$33.4K ﹤0.01% 3272
2024
Q2
$242K Buy
108,790
+92,391
+563% +$205K ﹤0.01% 3416
2024
Q1
$87.6K Hold
16,399
﹤0.01% 3316
2023
Q4
$24.3K Hold
16,399
﹤0.01% 3469
2023
Q3
$22.8K Hold
16,399
﹤0.01% 3501
2023
Q2
$24.1K Hold
16,399
﹤0.01% 3536
2023
Q1
$27.1K Hold
16,399
﹤0.01% 3465
2022
Q4
$23K Hold
16,399
﹤0.01% 3483
2022
Q3
$26K Hold
16,399
﹤0.01% 3455
2022
Q2
$37K Sell
16,399
-86,744
-84% -$196K ﹤0.01% 3432
2022
Q1
$256K Buy
103,143
+5,380
+6% +$13.4K ﹤0.01% 3261
2021
Q4
$588K Hold
97,763
﹤0.01% 3094
2021
Q3
$652K Buy
97,763
+12,146
+14% +$81K ﹤0.01% 3052
2021
Q2
$570K Buy
+85,617
New +$570K ﹤0.01% 3123
2020
Q4
Sell
-11,636
Closed -$166K 3399
2020
Q3
$166K Buy
+11,636
New +$166K ﹤0.01% 3206
2017
Q2
Sell
-491
Closed -$41K 3108
2017
Q1
$41K Hold
491
﹤0.01% 3044
2016
Q4
$75K Hold
491
﹤0.01% 3055
2016
Q3
$159K Hold
491
﹤0.01% 2957
2016
Q2
$161K Hold
491
﹤0.01% 2994
2016
Q1
$165K Hold
491
﹤0.01% 2936
2015
Q4
$191K Hold
491
﹤0.01% 2969
2015
Q3
$202K Hold
491
﹤0.01% 2955
2015
Q2
$359K Buy
+491
New +$359K ﹤0.01% 2798